SCHEMBL15959660

SCHEMBL15959660

CCCCOc1c(C(=O)O)ccn(Cc2ccccc2)c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.53
MAPK14 Q16539 6/20 0.46
BRD4 O60885 2/20 0.46
BRD2 P25440 1/20 0.45
BRD3 Q15059 1/20 0.45
BRDT Q58F21 1/20 0.45
EGLN1 Q9GZT9 2/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 2/20 0.43
AGTR1 P30556 1/20 0.43
AGTR2 P50052 1/20 0.43
KDM4E B2RXH2 1/20 0.43
RECQL P46063 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14846520 0.84 MAPK14 (0.57) NOTUMMAPK14BRD4BRD2BRD3
SCHEMBL16644656 0.81 RARB (0.42) RECQLTSHR
SCHEMBL13367288 0.79 CNR2 (0.43) KDM4ESMN1; SMN2ALDH1A1RAB9ATSHR
SCHEMBL13367222 0.78 NOTUM (0.56) NOTUMMEN1KMT2AMAPTAGTR1
SCHEMBL14470357 0.75 MAPK14 (0.51) MAPK14BRD4BRD2BRD3BRDT
SCHEMBL12594186 0.74 MAPK14 (0.71) MAPK14BRD4BRD2BRD3BRDT
SCHEMBL12594316 0.73 MAPK14 (0.53) MAPK14BRD4MEN1KMT2AMAPT
SCHEMBL12502722 0.73 NOTUM (0.58) NOTUMMAPK14BRD4BRD2BRD3
SCHEMBL17980842 0.73 TSHR (0.53) MEN1KMT2AKDM4ERECQLALDH1A1
SCHEMBL12697313 0.73 TSHR (0.51) KDM4ESMN1; SMN2ALDH1A1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2760839-B1 PYRIDINEDIONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL MYERS SQUIBB CO (US) 2015-11-25 EP disclosed
US-8993557-B2 Pyridinedione carboxamide inhibitors of endothelial lipase BRISTOL-MYERS SQUIBB COMPANY (US) 2015-03-31 US disclosed
US-20140235608-A1 PYRIDINEDIONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL-MYERS SQUIBB COMPANY (US) 2014-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140235608-A1 PYRIDINEDIONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE LIPG, PNLIP, LPL NOTUM 41/4885MAPK14 1498/4885BRD4 249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.